nodes	percent_of_prediction	percent_of_DWPC	metapath
Methotrimeprazine—Necrotising colitis—Epirubicin—bone cancer	0.0175	0.199	CcSEcCtD
Methotrimeprazine—Necrotising colitis—Doxorubicin—bone cancer	0.0162	0.184	CcSEcCtD
Methotrimeprazine—DRD5—eyelid—bone cancer	0.0089	0.403	CbGeAlD
Methotrimeprazine—Clomipramine—GSTP1—bone cancer	0.0069	0.194	CrCbGaD
Methotrimeprazine—Liver injury—Cisplatin—bone cancer	0.00467	0.0531	CcSEcCtD
Methotrimeprazine—Alimemazine—CYP3A4—bone cancer	0.00461	0.13	CrCbGaD
Methotrimeprazine—Sudden death—Methotrexate—bone cancer	0.00421	0.0479	CcSEcCtD
Methotrimeprazine—Mequitazine—CYP3A4—bone cancer	0.00396	0.112	CrCbGaD
Methotrimeprazine—Hepatocellular injury—Cisplatin—bone cancer	0.00393	0.0447	CcSEcCtD
Methotrimeprazine—Diltiazem—CYP3A4—bone cancer	0.00356	0.1	CrCbGaD
Methotrimeprazine—HRH1—nose—bone cancer	0.00295	0.134	CbGeAlD
Methotrimeprazine—Pipotiazine—CYP3A4—bone cancer	0.00282	0.0794	CrCbGaD
Methotrimeprazine—Prochlorperazine—CYP3A4—bone cancer	0.00269	0.0758	CrCbGaD
Methotrimeprazine—Orthostatic hypotension—Cisplatin—bone cancer	0.00261	0.0296	CcSEcCtD
Methotrimeprazine—Liver injury—Epirubicin—bone cancer	0.0024	0.0273	CcSEcCtD
Methotrimeprazine—Clomipramine—CYP3A4—bone cancer	0.00223	0.0627	CrCbGaD
Methotrimeprazine—Liver injury—Doxorubicin—bone cancer	0.00222	0.0252	CcSEcCtD
Methotrimeprazine—Trimipramine—CYP3A4—bone cancer	0.00205	0.0577	CrCbGaD
Methotrimeprazine—Hepatocellular injury—Epirubicin—bone cancer	0.00202	0.0229	CcSEcCtD
Methotrimeprazine—HTR2A—trigeminal nerve—bone cancer	0.00193	0.0876	CbGeAlD
Methotrimeprazine—Perphenazine—CYP3A4—bone cancer	0.00193	0.0542	CrCbGaD
Methotrimeprazine—Hepatocellular injury—Doxorubicin—bone cancer	0.00187	0.0212	CcSEcCtD
Methotrimeprazine—Photosensitivity—Methotrexate—bone cancer	0.00178	0.0203	CcSEcCtD
Methotrimeprazine—Promazine—CYP3A4—bone cancer	0.00174	0.0489	CrCbGaD
Methotrimeprazine—Photosensitivity—Epirubicin—bone cancer	0.00167	0.019	CcSEcCtD
Methotrimeprazine—Photosensitivity—Doxorubicin—bone cancer	0.00154	0.0175	CcSEcCtD
Methotrimeprazine—Chlorpromazine—CYP3A4—bone cancer	0.00153	0.043	CrCbGaD
Methotrimeprazine—Imipramine—CYP3A4—bone cancer	0.00152	0.0428	CrCbGaD
Methotrimeprazine—HTR2A—cranial nerve—bone cancer	0.00138	0.0624	CbGeAlD
Methotrimeprazine—Tachycardia—Cisplatin—bone cancer	0.00137	0.0156	CcSEcCtD
Methotrimeprazine—HTR2A—vertebral column—bone cancer	0.00135	0.0612	CbGeAlD
Methotrimeprazine—Orthostatic hypotension—Epirubicin—bone cancer	0.00134	0.0152	CcSEcCtD
Methotrimeprazine—Orthostatic hypotension—Doxorubicin—bone cancer	0.00124	0.0141	CcSEcCtD
Methotrimeprazine—Photosensitivity reaction—Methotrexate—bone cancer	0.00123	0.014	CcSEcCtD
Methotrimeprazine—Drowsiness—Methotrexate—bone cancer	0.00121	0.0137	CcSEcCtD
Methotrimeprazine—HTR2A—hindlimb—bone cancer	0.00116	0.0526	CbGeAlD
Methotrimeprazine—Photosensitivity reaction—Epirubicin—bone cancer	0.00116	0.0131	CcSEcCtD
Methotrimeprazine—Weight increased—Epirubicin—bone cancer	0.00115	0.0131	CcSEcCtD
Methotrimeprazine—Drowsiness—Epirubicin—bone cancer	0.00113	0.0128	CcSEcCtD
Methotrimeprazine—Agranulocytosis—Methotrexate—bone cancer	0.00113	0.0128	CcSEcCtD
Methotrimeprazine—Jaundice—Epirubicin—bone cancer	0.0011	0.0125	CcSEcCtD
Methotrimeprazine—Photosensitivity reaction—Doxorubicin—bone cancer	0.00107	0.0122	CcSEcCtD
Methotrimeprazine—Weight increased—Doxorubicin—bone cancer	0.00107	0.0121	CcSEcCtD
Methotrimeprazine—Agranulocytosis—Epirubicin—bone cancer	0.00105	0.012	CcSEcCtD
Methotrimeprazine—Drowsiness—Doxorubicin—bone cancer	0.00104	0.0119	CcSEcCtD
Methotrimeprazine—Hypersensitivity—Cisplatin—bone cancer	0.00103	0.0117	CcSEcCtD
Methotrimeprazine—Jaundice—Doxorubicin—bone cancer	0.00102	0.0116	CcSEcCtD
Methotrimeprazine—HTR2A—appendage—bone cancer	0.000996	0.0451	CbGeAlD
Methotrimeprazine—Agranulocytosis—Doxorubicin—bone cancer	0.000975	0.0111	CcSEcCtD
Methotrimeprazine—Tachycardia—Epirubicin—bone cancer	0.000703	0.00799	CcSEcCtD
Methotrimeprazine—Somnolence—Methotrexate—bone cancer	0.000684	0.00778	CcSEcCtD
Methotrimeprazine—Tachycardia—Doxorubicin—bone cancer	0.00065	0.00739	CcSEcCtD
Methotrimeprazine—Somnolence—Epirubicin—bone cancer	0.00064	0.00728	CcSEcCtD
Methotrimeprazine—Constipation—Epirubicin—bone cancer	0.000616	0.007	CcSEcCtD
Methotrimeprazine—Somnolence—Doxorubicin—bone cancer	0.000592	0.00673	CcSEcCtD
Methotrimeprazine—Constipation—Doxorubicin—bone cancer	0.00057	0.00648	CcSEcCtD
Methotrimeprazine—Hypersensitivity—Methotrexate—bone cancer	0.000567	0.00644	CcSEcCtD
Methotrimeprazine—Hypersensitivity—Epirubicin—bone cancer	0.00053	0.00603	CcSEcCtD
Methotrimeprazine—Hypersensitivity—Doxorubicin—bone cancer	0.000491	0.00558	CcSEcCtD
Methotrimeprazine—HTR2C—spinal cord—bone cancer	0.000376	0.017	CbGeAlD
Methotrimeprazine—HRH1—connective tissue—bone cancer	0.00034	0.0154	CbGeAlD
Methotrimeprazine—ADRA2A—connective tissue—bone cancer	0.000334	0.0151	CbGeAlD
Methotrimeprazine—ADRA2C—tendon—bone cancer	0.000288	0.013	CbGeAlD
Methotrimeprazine—HTR2A—connective tissue—bone cancer	0.000284	0.0129	CbGeAlD
Methotrimeprazine—ADRA2C—spinal cord—bone cancer	0.000278	0.0126	CbGeAlD
Methotrimeprazine—HRH1—tendon—bone cancer	0.000234	0.0106	CbGeAlD
Methotrimeprazine—ADRA2A—tendon—bone cancer	0.00023	0.0104	CbGeAlD
Methotrimeprazine—CYP2E1—tendon—bone cancer	0.000225	0.0102	CbGeAlD
Methotrimeprazine—ADRA2A—Metabolism—GNA11—bone cancer	0.000223	0.000261	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—SMO—bone cancer	0.000223	0.00026	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—IL3—bone cancer	0.000222	0.00026	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—SMO—bone cancer	0.000222	0.00026	CbGpPWpGaD
Methotrimeprazine—ADRA2A—spinal cord—bone cancer	0.000222	0.01	CbGeAlD
Methotrimeprazine—CHRM4—Signaling Pathways—IGF1R—bone cancer	0.00022	0.000258	CbGpPWpGaD
Methotrimeprazine—CHRM3—Metabolism—CYP3A4—bone cancer	0.00022	0.000257	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—SMO—bone cancer	0.00022	0.000257	CbGpPWpGaD
Methotrimeprazine—DRD5—Signaling Pathways—KIT—bone cancer	0.000219	0.000257	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—ATF1—bone cancer	0.000219	0.000256	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—SMO—bone cancer	0.000219	0.000256	CbGpPWpGaD
Methotrimeprazine—CYP2E1—Metabolism—DHFR—bone cancer	0.000219	0.000256	CbGpPWpGaD
Methotrimeprazine—CYP2E1—spinal cord—bone cancer	0.000217	0.00982	CbGeAlD
Methotrimeprazine—HTR2C—Signaling Pathways—IL3—bone cancer	0.000214	0.00025	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—TGFBR2—bone cancer	0.000214	0.00025	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—ATF1—bone cancer	0.000213	0.000249	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Metabolism—GSTP1—bone cancer	0.000213	0.000249	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—IGF1R—bone cancer	0.000211	0.000247	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—TGFBR2—bone cancer	0.000211	0.000247	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—TGFBR2—bone cancer	0.000211	0.000247	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—ATF1—bone cancer	0.00021	0.000245	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—GNA11—bone cancer	0.000208	0.000243	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—IL3—bone cancer	0.000208	0.000243	CbGpPWpGaD
Methotrimeprazine—DRD5—Signaling Pathways—BRAF—bone cancer	0.000206	0.000241	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—GNA11—bone cancer	0.000205	0.000239	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—IL3—bone cancer	0.000205	0.000239	CbGpPWpGaD
Methotrimeprazine—CYP2E1—Metabolism—GNA11—bone cancer	0.000204	0.000239	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—GNA11—bone cancer	0.000204	0.000239	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—SMO—bone cancer	0.000204	0.000238	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—GNA11—bone cancer	0.000204	0.000238	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—GNA11—bone cancer	0.000203	0.000237	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Metabolism—CYP3A4—bone cancer	0.000202	0.000236	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—IGF1R—bone cancer	0.000201	0.000235	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—GNA11—bone cancer	0.000201	0.000235	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—GNA11—bone cancer	0.0002	0.000235	CbGpPWpGaD
Methotrimeprazine—DRD5—Signaling by GPCR—EGFR—bone cancer	0.0002	0.000234	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—IGF1R—bone cancer	0.000198	0.000232	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—IGF1R—bone cancer	0.000198	0.000232	CbGpPWpGaD
Methotrimeprazine—HTR2A—tendon—bone cancer	0.000195	0.00885	CbGeAlD
Methotrimeprazine—DRD2—Signaling Pathways—ATF1—bone cancer	0.000193	0.000226	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—TGFBR2—bone cancer	0.00019	0.000223	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—ATF1—bone cancer	0.00019	0.000223	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—ATF1—bone cancer	0.00019	0.000222	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—ATF1—bone cancer	0.000189	0.000221	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—ATF1—bone cancer	0.000189	0.000221	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—IL3—bone cancer	0.000189	0.000221	CbGpPWpGaD
Methotrimeprazine—HTR2A—spinal cord—bone cancer	0.000188	0.00853	CbGeAlD
Methotrimeprazine—CHRM3—Metabolism—GSTP1—bone cancer	0.000188	0.00022	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—ATF1—bone cancer	0.000187	0.000219	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—ATF1—bone cancer	0.000186	0.000218	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—GNA11—bone cancer	0.000186	0.000218	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—IL3—bone cancer	0.000186	0.000217	CbGpPWpGaD
Methotrimeprazine—CYP2E1—Metabolism—CYP3A4—bone cancer	0.000185	0.000217	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—IL3—bone cancer	0.000185	0.000217	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—IL3—bone cancer	0.000185	0.000216	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—IL3—bone cancer	0.000184	0.000215	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—TGFBR2—bone cancer	0.000183	0.000214	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—IL3—bone cancer	0.000182	0.000213	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—IL3—bone cancer	0.000182	0.000213	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—IGF1R—bone cancer	0.000179	0.000209	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—TGFBR2—bone cancer	0.000178	0.000208	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—TGFBR2—bone cancer	0.000175	0.000205	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—ATF1—bone cancer	0.000173	0.000203	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Hemostasis—TP53—bone cancer	0.000173	0.000203	CbGpPWpGaD
Methotrimeprazine—DRD5—Signaling Pathways—MDM2—bone cancer	0.000173	0.000202	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Metabolism—GSTP1—bone cancer	0.000173	0.000202	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—IGF1R—bone cancer	0.000172	0.000201	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—IL3—bone cancer	0.000169	0.000198	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—ENO2—bone cancer	0.000167	0.000196	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—IGF1R—bone cancer	0.000167	0.000196	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—IGF1R—bone cancer	0.000165	0.000193	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling Pathways—KIT—bone cancer	0.000162	0.000189	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Hemostasis—TP53—bone cancer	0.000162	0.000189	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—TGFBR2—bone cancer	0.000161	0.000189	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling Pathways—KIT—bone cancer	0.00016	0.000187	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—TGFBR2—bone cancer	0.000159	0.000186	CbGpPWpGaD
Methotrimeprazine—CYP2E1—Metabolism—GSTP1—bone cancer	0.000159	0.000186	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—TGFBR2—bone cancer	0.000158	0.000185	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—TGFBR2—bone cancer	0.000158	0.000185	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—TGFBR2—bone cancer	0.000157	0.000184	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—TGFBR2—bone cancer	0.000156	0.000182	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—TGFBR2—bone cancer	0.000155	0.000182	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—DHFR—bone cancer	0.000155	0.000182	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—KIT—bone cancer	0.000153	0.000179	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling Pathways—BRAF—bone cancer	0.000152	0.000178	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—IGF1R—bone cancer	0.000152	0.000178	CbGpPWpGaD
Methotrimeprazine—DRD5—Signaling Pathways—JUN—bone cancer	0.00015	0.000176	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling Pathways—BRAF—bone cancer	0.00015	0.000176	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—IGF1R—bone cancer	0.000149	0.000175	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—IGF1R—bone cancer	0.000149	0.000174	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—IGF1R—bone cancer	0.000148	0.000174	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—IGF1R—bone cancer	0.000148	0.000173	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling by GPCR—EGFR—bone cancer	0.000147	0.000173	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—IGF1R—bone cancer	0.000147	0.000172	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—IGF1R—bone cancer	0.000146	0.000171	CbGpPWpGaD
Methotrimeprazine—DRD5—Signaling Pathways—MMP9—bone cancer	0.000146	0.000171	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—KIT—bone cancer	0.000146	0.000171	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling by GPCR—EGFR—bone cancer	0.000146	0.00017	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—GNA11—bone cancer	0.000145	0.00017	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—TGFBR2—bone cancer	0.000144	0.000169	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—KIT—bone cancer	0.000144	0.000168	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—KIT—bone cancer	0.000144	0.000168	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—BRAF—bone cancer	0.000144	0.000168	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—ENO2—bone cancer	0.000142	0.000166	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling by GPCR—EGFR—bone cancer	0.000139	0.000163	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—BRAF—bone cancer	0.000137	0.00016	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—IGF1R—bone cancer	0.000136	0.000159	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—BRAF—bone cancer	0.000135	0.000158	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—BRAF—bone cancer	0.000135	0.000158	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling by GPCR—EGFR—bone cancer	0.000133	0.000155	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—CYP3A4—bone cancer	0.000132	0.000154	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—DHFR—bone cancer	0.000132	0.000154	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Hemostasis—TP53—bone cancer	0.000131	0.000154	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling by GPCR—EGFR—bone cancer	0.000131	0.000153	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling by GPCR—EGFR—bone cancer	0.000131	0.000153	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—KIT—bone cancer	0.00013	0.000152	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling Pathways—MDM2—bone cancer	0.000127	0.000149	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling Pathways—MDM2—bone cancer	0.000126	0.000147	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—KIT—bone cancer	0.000125	0.000146	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—GNA11—bone cancer	0.000123	0.000144	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—BRAF—bone cancer	0.000122	0.000143	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—KIT—bone cancer	0.000121	0.000142	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—MDM2—bone cancer	0.00012	0.000141	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—KIT—bone cancer	0.000119	0.00014	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling by GPCR—EGFR—bone cancer	0.000118	0.000138	CbGpPWpGaD
Methotrimeprazine—DRD5—Signaling Pathways—EGFR—bone cancer	0.000118	0.000138	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—BRAF—bone cancer	0.000117	0.000137	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—MDM2—bone cancer	0.000115	0.000134	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—BRAF—bone cancer	0.000114	0.000133	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling by GPCR—EGFR—bone cancer	0.000114	0.000133	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—MDM2—bone cancer	0.000113	0.000133	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—MDM2—bone cancer	0.000113	0.000133	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—GSTP1—bone cancer	0.000112	0.000132	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—BRAF—bone cancer	0.000112	0.000131	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—CYP3A4—bone cancer	0.000111	0.00013	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	0.000111	0.00013	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling Pathways—JUN—bone cancer	0.000111	0.00013	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling by GPCR—EGFR—bone cancer	0.00011	0.000129	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Metabolism—PTGS2—bone cancer	0.00011	0.000129	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—KIT—bone cancer	0.00011	0.000129	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling Pathways—JUN—bone cancer	0.000109	0.000128	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling by GPCR—EGFR—bone cancer	0.000109	0.000127	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—KIT—bone cancer	0.000108	0.000127	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—KIT—bone cancer	0.000108	0.000126	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling Pathways—MMP9—bone cancer	0.000108	0.000126	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—KIT—bone cancer	0.000108	0.000126	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—KIT—bone cancer	0.000107	0.000126	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling Pathways—MMP9—bone cancer	0.000106	0.000124	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—KIT—bone cancer	0.000106	0.000124	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—KIT—bone cancer	0.000106	0.000124	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—JUN—bone cancer	0.000105	0.000123	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—BRAF—bone cancer	0.000103	0.000121	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—MDM2—bone cancer	0.000102	0.00012	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—MMP9—bone cancer	0.000102	0.000119	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—BRAF—bone cancer	0.000102	0.000119	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—BRAF—bone cancer	0.000102	0.000119	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—BRAF—bone cancer	0.000101	0.000118	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—BRAF—bone cancer	0.000101	0.000118	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling by GPCR—EGFR—bone cancer	0.0001	0.000117	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—BRAF—bone cancer	9.99e-05	0.000117	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—JUN—bone cancer	9.98e-05	0.000117	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—BRAF—bone cancer	9.96e-05	0.000117	CbGpPWpGaD
Methotrimeprazine—DRD5—Signaling Pathways—TP53—bone cancer	9.91e-05	0.000116	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling by GPCR—EGFR—bone cancer	9.86e-05	0.000115	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—KIT—bone cancer	9.85e-05	0.000115	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—JUN—bone cancer	9.84e-05	0.000115	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—JUN—bone cancer	9.84e-05	0.000115	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling by GPCR—EGFR—bone cancer	9.84e-05	0.000115	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—MDM2—bone cancer	9.82e-05	0.000115	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling by GPCR—EGFR—bone cancer	9.81e-05	0.000115	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling by GPCR—EGFR—bone cancer	9.78e-05	0.000114	CbGpPWpGaD
Methotrimeprazine—CHRM3—Metabolism—PTGS2—bone cancer	9.75e-05	0.000114	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—MMP9—bone cancer	9.71e-05	0.000114	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling by GPCR—EGFR—bone cancer	9.68e-05	0.000113	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling by GPCR—EGFR—bone cancer	9.66e-05	0.000113	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—MMP9—bone cancer	9.58e-05	0.000112	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—MMP9—bone cancer	9.58e-05	0.000112	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—MDM2—bone cancer	9.55e-05	0.000112	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—GSTP1—bone cancer	9.53e-05	0.000112	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—MDM2—bone cancer	9.4e-05	0.00011	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—BRAF—bone cancer	9.26e-05	0.000108	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling by GPCR—EGFR—bone cancer	8.97e-05	0.000105	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Metabolism—PTGS2—bone cancer	8.94e-05	0.000105	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—JUN—bone cancer	8.89e-05	0.000104	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling Pathways—EGFR—bone cancer	8.71e-05	0.000102	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—MDM2—bone cancer	8.67e-05	0.000101	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—MMP9—bone cancer	8.65e-05	0.000101	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling Pathways—EGFR—bone cancer	8.6e-05	0.000101	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—JUN—bone cancer	8.53e-05	9.99e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—MDM2—bone cancer	8.53e-05	9.98e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—MDM2—bone cancer	8.51e-05	9.96e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—MDM2—bone cancer	8.48e-05	9.93e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—MDM2—bone cancer	8.45e-05	9.89e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—MDM2—bone cancer	8.37e-05	9.8e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—MDM2—bone cancer	8.35e-05	9.77e-05	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—MMP9—bone cancer	8.3e-05	9.72e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—JUN—bone cancer	8.3e-05	9.72e-05	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—EGFR—bone cancer	8.23e-05	9.63e-05	CbGpPWpGaD
Methotrimeprazine—CYP2E1—Metabolism—PTGS2—bone cancer	8.21e-05	9.61e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—JUN—bone cancer	8.17e-05	9.56e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—MMP9—bone cancer	8.08e-05	9.45e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—MMP9—bone cancer	7.95e-05	9.3e-05	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—EGFR—bone cancer	7.84e-05	9.18e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—MDM2—bone cancer	7.76e-05	9.08e-05	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—EGFR—bone cancer	7.74e-05	9.06e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—EGFR—bone cancer	7.74e-05	9.06e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—JUN—bone cancer	7.53e-05	8.82e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—JUN—bone cancer	7.41e-05	8.67e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—JUN—bone cancer	7.4e-05	8.66e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—JUN—bone cancer	7.37e-05	8.63e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—JUN—bone cancer	7.35e-05	8.6e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—MMP9—bone cancer	7.33e-05	8.58e-05	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling Pathways—TP53—bone cancer	7.32e-05	8.56e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—JUN—bone cancer	7.28e-05	8.52e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—JUN—bone cancer	7.26e-05	8.49e-05	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling Pathways—TP53—bone cancer	7.22e-05	8.45e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—MMP9—bone cancer	7.21e-05	8.44e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—MMP9—bone cancer	7.2e-05	8.42e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—MMP9—bone cancer	7.17e-05	8.39e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—MMP9—bone cancer	7.15e-05	8.37e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—MMP9—bone cancer	7.08e-05	8.29e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—MMP9—bone cancer	7.06e-05	8.26e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—EGFR—bone cancer	6.99e-05	8.18e-05	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—TP53—bone cancer	6.91e-05	8.09e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—JUN—bone cancer	6.74e-05	7.89e-05	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—EGFR—bone cancer	6.71e-05	7.85e-05	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—TP53—bone cancer	6.59e-05	7.71e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—MMP9—bone cancer	6.56e-05	7.68e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—EGFR—bone cancer	6.53e-05	7.64e-05	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—TP53—bone cancer	6.5e-05	7.61e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—TP53—bone cancer	6.5e-05	7.61e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—EGFR—bone cancer	6.42e-05	7.52e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—EGFR—bone cancer	5.92e-05	6.93e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—TP53—bone cancer	5.87e-05	6.87e-05	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—PTGS2—bone cancer	5.83e-05	6.82e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—EGFR—bone cancer	5.83e-05	6.82e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—EGFR—bone cancer	5.81e-05	6.81e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—EGFR—bone cancer	5.8e-05	6.78e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—EGFR—bone cancer	5.78e-05	6.76e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—EGFR—bone cancer	5.72e-05	6.7e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—EGFR—bone cancer	5.71e-05	6.68e-05	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—TP53—bone cancer	5.63e-05	6.59e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—TP53—bone cancer	5.48e-05	6.41e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—TP53—bone cancer	5.39e-05	6.31e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—EGFR—bone cancer	5.3e-05	6.2e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—TP53—bone cancer	4.97e-05	5.82e-05	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—PTGS2—bone cancer	4.94e-05	5.78e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—TP53—bone cancer	4.89e-05	5.73e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—TP53—bone cancer	4.88e-05	5.71e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—TP53—bone cancer	4.87e-05	5.7e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—TP53—bone cancer	4.85e-05	5.68e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—TP53—bone cancer	4.8e-05	5.62e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—TP53—bone cancer	4.79e-05	5.61e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—TP53—bone cancer	4.45e-05	5.21e-05	CbGpPWpGaD
